Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 63.00
Ask: 67.00
Change: -0.50 (-0.76%)
Spread: 4.00 (6.349%)
Open: 65.50
High: 65.50
Low: 65.00
Prev. Close: 65.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Innovative Technology Contract Awarded

1 Mar 2017 07:00

RNS Number : 1394Y
Tissue Regenix Group PLC
01 March 2017
 

Tissue Regenix Group plc

Innovative Technology Contract Awarded

 

DermaPure® Receives Innovative Technology Contract from Vizient, Inc.

 

Leeds, 01 March 2017 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group"), the regenerative medical devices company, announces effective from today its wound care product, DermaPure®, has been awarded an Innovative Technology contract from Vizient, Inc., the largest member-owned health care company in the United States.

The contract was based on a recommendation of DermaPure® by hospital representatives who serve on a Vizient member-led council with expertise in this category. Innovative Technology contracts are reserved for technologies that demonstrate an ability to enhance clinical care or patient safety, and those that improve an organization's care delivery and business model.

Antony Odell, CEO, Tissue Regenix Group plc commented: "The approval by Vizient under their Innovative Technology contracting process reinforces Vizient member support for DermaPure®. We look forward to working with Vizient members to bring DermaPure® to the wider patient population."

"Due to the number of products and services being released and marketed as 'innovative', member hospitals find value in the thorough innovative technology review process in place at Vizient to help them identify products worth consideration for use at their own facilities," said Debbie Archer, director of procurement and leader of Vizient's Innovative Technology program for suppliers. "After a full review of DermaPure, Vizient's member council agreed this solution offers unique and incremental benefit over other products available on the market today, and recommended it for an Innovative Technology contract."

 

 

 

For more Information:

 

Tissue Regenix Group plc

Caitlin Pearson Corporate Communications Director

 

Tel: 0330 430 3073

Jefferies International Ltd

Simon Hardy / Harry Nicholas

 

Tel: 020 7029 8000

 

 

About Tissue Regenix

Tissue Regenix is a leading medical devices company in the field of regenerative medicine. The company's patented decellularisation ('dCELL®') technology removes DNA and other cellular material from animal and human tissue leaving an acellular tissue scaffold which is not rejected by the patient's body which can then be used to repair diseased or worn out body parts. The potential applications of this process are diverse and address many critical clinical needs such as vascular disease, heart valve replacement and knee repair.

 Tissue Regenix was formed in 2006 when it was spun-out from the University of Leeds. The company commercialises academic research conducted by our partners around the World.

 In November 2012 Tissue Regenix Group plc set up a subsidiary company in the United States - 'Tissue Regenix Wound Care Inc.', as part of its commercialisation strategy for its dCELL® technology platform. 

 

About Vizient

Vizient, Inc. represents the combined strengths of the organizations formerly known as VHA Inc., University HealthSystem Consortium, Novation and MedAssets' Spend and Clinical Resource Management. Since 2003, nearly 2200 new and innovative products and technologies have been submitted through the Vizient Innovative Technology program. Vizient works with member-led councils and task forces to identify and review potentially innovative products. If it is determined that a product is innovative, a contract may be awarded outside of Vizient's competitive bid cycle.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTPGUCWPUPMPGR
Date   Source Headline
2nd Feb 20067:01 amRNSHolding(s) in Company
2nd Feb 20067:01 amRNSHolding(s) in Company
30th Jan 20068:56 amRNSHolding(s) in Company
26th Jan 20065:53 pmRNSHolding(s) in Company
26th Jan 20065:50 pmRNSHolding(s) in Company
25th Jan 20063:31 pmRNSAdditional Listing
16th Jan 20067:00 amRNSTrading Statement
3rd Jan 20063:35 pmRNSDirector/PDMR Shareholding
9th Dec 200512:08 pmRNSHolding(s) in Company
23rd Nov 20057:01 amRNSDirector/PDMR Shareholding
16th Nov 20053:55 pmRNSTransaction in Own Shares
15th Nov 20052:35 pmRNSAdditional Listing
14th Nov 200512:48 pmRNSDirector/PDMR Shareholding
3rd Nov 200511:09 amRNSIssue of Equity
3rd Nov 20059:37 amRNSDirector/PDMR Shareholding
31st Oct 20057:00 amRNSBoard Appointment
26th Oct 20058:09 amRNSAdditional Listing
7th Oct 200511:57 amRNSAdditional Listing
5th Oct 200511:51 amRNSAdditional Listing
3rd Oct 20054:50 pmRNSDirector/PDMR Shareholding
28th Sep 20052:43 pmRNSDirector/PDMR Shareholding
28th Sep 20058:35 amRNSClarification Announcement
26th Sep 20057:02 amRNSInterim Results
22nd Sep 20059:22 amRNSHolding(s) in Company
21st Sep 20053:29 pmRNSBoard appointment
20th Sep 20054:02 pmRNSAdditional Listing
12th Sep 200512:32 pmRNSNotice of Results
12th Sep 200511:11 amRNSAdditional Listing
6th Sep 20057:01 amRNSHolding(s) in Company
26th Aug 20052:47 pmRNSAdditional Listing
26th Aug 20058:49 amRNSDirectorate Change
25th Aug 20058:18 amRNSAdditional Listing
24th Aug 200512:11 pmRNSRecommended Offer for Anker
17th Aug 20055:13 pmRNSAnker acquisition update
17th Aug 200511:13 amRNSAcquisition
15th Aug 20057:01 amRNSOffer Update
12th Aug 200512:01 pmRNSRule 8.3- (Torex Retail)
12th Aug 200511:35 amRNSRule 8.1- Torex Retail PLC
11th Aug 20053:22 pmRNSRule 8.3-Torex Retail-Amendmt
11th Aug 200511:43 amRNSRule 8.1- TOREX Retail
11th Aug 200511:16 amRNSRule 8.3- Torex Retail PLC
11th Aug 200511:08 amRNSRule 8.1- Torex Retail PLC
11th Aug 20057:00 amRNSCancellation of Listing
10th Aug 20054:12 pmRNSResult of EGM
9th Aug 20053:50 pmRNSRule 8.3- Torex Retail PLC
9th Aug 20053:25 pmRNSEPT Disclosure
9th Aug 200511:50 amRNSRule 8.3- Torex Retail PLC
9th Aug 200511:23 amRNSRule 8.1- Torex Retail PLC
8th Aug 200511:12 amRNSRule 8.1- Torex Retail PLC
5th Aug 200511:58 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.